Celixir announces US FDA approval of the IND application for cell therapy Heartcel Celixir announces US FDA approval of the IND application for cell therapy HeartcelTM FDA IND and UK MHRA CTA approval both achieved in H1 2018 Potentially pivotal heart failure trial of up to 250...